Tag: Hatch-Waxman Act
FDA Safety Alerts Explained: How Generic Drug Warnings Work
Jun, 13 2026Learn how FDA safety alerts work for generic drugs, why labeling lags behind brand names, and what you can do to stay safe.
READ MORE
Paragraph IV Certifications: How Generics Challenge Drug Patents
May, 16 2026Explore how Paragraph IV certifications allow generic drug makers to challenge brand-name patents under the Hatch-Waxman Act. Learn about the 180-day exclusivity, litigation risks, and strategic impacts on drug pricing.
READ MORE